Christian Chatenay‐Rivauday

Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials

Christine Fritsch, Alan Huang, Christian Chatenay‐Rivauday et al. · Molecular Cancer Therapeutics · 2014 · 496 citations

Medicine, Oncology, Pharmacology +16

Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Fred Harbinski, Vanessa J. Craig, Sneha Sanghavi et al. · Cancer Discovery · 2012 · 107 citations

Medicine, Molecular Biology, Oncology +17

Involvement of alpha5beta1 integrins in interleukin 8 production induced by oral viridans streptococcal protein I/IIf in cultured endothelial cells

Souad Al-Okla, Christian Chatenay‐Rivauday, Jean‐Paul Klein et al. · Cellular Microbiology · 1999 · 28 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The A and the extended V N‐terminal regions of streptococcal protein I/IIf mediate the production of tumour necrosis factor α in the monocyte cell line THP‐1

Christian Chatenay‐Rivauday, Innocent Yamodo, Michel‐Angelo Sciotti et al. · Molecular Microbiology · 1998 · 27 citations

Life Sciences, Biochemistry, Immunology +9

Caveolae: biochemical analysis

Christian Chatenay‐Rivauday, Zeynep Petek Çakar, Paul Jenö et al. · Molecular Biology Reports · 2004 · 21 citations